Single step functionalization and cross-linking of hyaluronic acid
View Patent ↗A process for manufacturing a cross-linked hyaluronic acid (HA) containing a functionalizing group including the step of reacting HA with a mixture of: (i) a first cross-linking agent selected from the group of bifunctional epoxides and polyfunctional epoxides, and (ii) a functionalized agent of a functionalizing group coupled via a 1,2,3-triazole linkage to a second cross-linking agent selected from the group of bifunctional epoxides and polyfunctional epoxides, to obtain a cross-linked HA containing the functionalizing group. The process provides a cross-linked hyaluronic acid (HA) containing a functionalizing group. The process utilizes a functionalized agent of a functionalizing group coupled via a 1,2,3-triazole linkage to a cross-linking agent.
1. A process for manufacturing a cross-linked hyaluronic acid (HA) containing a functionalizing group, comprising a step of reacting HA in a single step with a mixture of:
(i) a first cross-linking agent selected from a group consisting of bifunctional epoxides and polyfunctional epoxides, and
(ii) a functionalized agent, consisting of a functionalizing group coupled via a 1,2,3-triazole linkage to a second cross-linking agent selected from the group consisting of bifunctional epoxides and polyfunctional epoxides, to obtain a cross-linked HA containing the functionalizing group.
2. A process according to claim 1 , wherein the first and second cross-linking agents are independently selected from the group consisting of bifunctional epoxides and polyfunctional epoxides, and wherein the reacting step is performed at a basic pH to provide ether cross-links both between the HA and the first cross-linking agent, and between the HA and the functionalized agent.
3. A process according to claim 2 , wherein the first and second cross-linking agents are independently selected from the group consisting of bifunctional epoxides.
4. A process according to claim 3 , wherein the first and second cross-linking agents are both butanediol diglycidyl ether (BDDE).
5. A process according to claim 1 , wherein the functionalizing group is an imaging agent.
6. A process according to claim 5 , wherein the imaging agent is fluorescein.